Merck & Co., Inc.

Click on Photographs
Where patients come first

Merck's focus on discovering and developing medicines and vaccines has resulted in products that have helped millions of patients around the world. We plan to drive the continued success of our franchises through new products, new indications and formulations for existing products, and clinical trials that demonstrate their safety and efficacy. The following is a list of selected Merck medicines and vaccines.

Arcoxia® (etoricoxib)
  • Osteoarthritis
  • Rheumatoid arthritis (adult)
  • Acute pain
  • Chronic low back pain
  • Dysmenorrhea (menstrual pain)
  • Acute gouty arthritis
Cancidas® (caspofungin acetate)
  • Empiric therapy for presumed fungal infections in febrile, neutropenic patients
  • Treatment of invasive aspergillosis in patients who did not respond to or were intolerant of other antifungal therapies
  • Candida infections: intra-abdominal abscesses, peritonitis (infections within the lining of the abdominal cavity), pleural space infections (infections within the lining of the lung)
  • Candidemia (bloodstream infection)
  • Esophageal candidiasis
Comvax® [Haemophilus b conjugate (meningococcal protein conjugate) and
hepatitis B (recombinant) vaccine]
  • Simultaneous vaccination against Haemophilus influenzae type b disease and hepatitis B disease
Cosopt® (dorzolamide hydrochloride and timolol maleate)
  • Lower intraocular pressure
Cozaar® (losartan potassium)
  • High blood pressure
  • Reduction in progression of renal disease in patients with Type 2 diabetes, hypertension and nephropathy
  • Reduction of stroke risk in patients with hypertension and left ventricular hypertrophy(1)
Crixivan® (indinavir sulfate)
  • Treatment of HIV infection in combination with antiretroviral agents
Emend® (aprepitant)
  • Prevention of nausea and vomiting induced by highly emetogenic chemotherapy
Fosamax® (alendronate sodium)
  • Treatment and prevention of postmenopausal osteoporosis
  • Reduction of osteoporotic fracture risk in postmenopausal women
  • Treatment of male osteoporosis to increase bone mass
  • Treatment of glucocorticoid-induced osteoporosis
  • Paget’s disease of the bone
Hyzaar® (losartan potassium and hydrochlorothiazide)
  • High blood pressure
Invanz® (ertapenem sodium)
  • Treatment of moderate to severe infections caused by susceptible strains of aerobic and anaerobic bacteria, such as complicated intra-abdominal and complicated skin and skin structure infections
Maxalt® (rizatriptan benzoate)
  • Acute migraine
M-M-R® II [measles, mumps and rubella
virus vaccine live]
  • Simultaneous vaccination against measles, mumps, rubella
Pneumovax® 23 [pneumococcal vaccine polyvalent]
  • Vaccination against pneumococcal disease
Primaxin® (imipenem and cilastatin)
  • Antibiotic
Propecia® (finasteride)
  • Treatment of male pattern hair loss
Proscar® (finasteride)
  • Treatment of symptomatic benign prostate enlargement
Recombivax HB® [hepatitis B vaccine (recombinant)]
  • Vaccination against hepatitis B
Singulair® (montelukast sodium)
  • Chronic asthma–adults and children as young as 12-months old
  • Seasonal allergic rhinitis–adults and children as young as age 2
Stocrin® (efavirenz)(2)
  • HIV infection
Timoptic-XE® (timolol maleate ophthalmic
gel forming solution)
  • Lower intraocular pressure
Trusopt® (dorzolamide hydrochloride)
  • Lower intraocular pressure
Vaqta® [hepatitis A vaccine inactivated]
  • Vaccination against hepatitis A
Varivax® [varicella virus vaccine live (Oka/Merck)]
  • Vaccination against chickenpox
Vytorin® (ezetimibe simvastatin)(3)
  • Elevated total cholesterol levels
  • Lower LDL cholesterol
  • Raise HDL cholesterol
  • Reduce triglycerides
Zetia® (ezetimibe)(3)
  • Elevated cholesterol levels
Zocor® (simvastatin)
  • Elevated total cholesterol levels
  • Associated total/coronary
    mortality(4)
  • Lower LDL cholesterol
  • Raise HDL cholesterol
  • Reduce triglycerides
  • Reduce stroke risk(4)

(1)There is evidence that this benefit does not apply to black patients.
(2)Efavirenz is marketed by Bristol-Myers Squibb as Sustiva in the U.S., Canada and certain European countries, and by Merck in the rest of the world as Stocrin.
(3)Vytorin (marketed as Inegy in many countries outside the U.S.) and Zetia (branded Ezetrol outside the U.S.) are marketed through a partnership with Schering-Plough Corporation.
(4)In patients with coronary heart disease or diabetes.

 Copyright © 2009-2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.  Privacy  Terms of Use  Sitemap